Science Shop
Advertisement
UK Approves CRISPR/Cas Drug Casgevy for Blood Disorders
The UK’s MHRA has greenlit Casgevy, a CRISPR/Cas gene-editing drug, for treating blood disorders. This groundbreaking approval offers hope to patients aged twelve and above
Lab-grown blood transfused to humans.
In the UK, scientists from the University of Bristol and other research institutions are working on producing human blood in the laboratory as part of
